Same Score, Different Disease: Why Your AHI Doesn't Tell the Whole Story

If you've been evaluated for sleep apnea, you've almost certainly been handed a number: your AHI, or apnea-hypopnea index, the count of times per hour your breathing stopped or shallowed during sleep. It's how the condition gets graded. Under 5 is normal, 5 to 15 is mild, 15 to 30 is moderate, over 30 is severe. That single number tends to drive the whole conversation about how serious your sleep apnea is and what to do about it.

The AHI is genuinely useful. But here's something most patients are never told: it describes how much is happening, not why. And that missing "why" turns out to matter enormously, because two people can walk in with the exact same AHI and actually have quite different diseases underneath, driven by different biology, producing different symptoms, and responding to different treatments. Understanding that distinction is one of the most important shifts happening in sleep medicine right now, and it's the difference between treating a number and treating a person.

The number is a measurement, not a mechanism

Think of the AHI like a fever thermometer. A temperature of 102 tells you something is wrong and roughly how intense it is, but it says nothing about the cause, whether it's the flu, a bacterial infection, or something else entirely. You wouldn't treat every fever the same way, because the right treatment depends on what's driving it. The AHI is similar: it measures the intensity of the problem, but not its source.

Sleep apnea has been dominated for years by this one metric, largely because it's straightforward to measure and it does correlate with risk. But counting events answers only the question "how many?" It leaves untouched the equally important question Dr. Taruj and other sleep physicians increasingly emphasize: "what is actually driving this particular patient's sleep apnea?" Two people can share an AHI of 12 and have almost nothing else in common about their condition.

Four people, same AHI, four different diseases

To make this concrete, imagine four different patients, each of whom gets a sleep study back showing an AHI of 12, moderate sleep apnea. On paper, identical. In reality, researchers have identified several distinct underlying mechanisms, often called endotypes, and these four patients might each be driven by a different one ^{[1, 2]}.

Patient one has a highly collapsible airway. For this person, the problem is mainly anatomical: the upper airway is structurally prone to collapsing during sleep, whether because of the shape of the jaw and throat, the soft tissue, or weight around the neck. This is the "classic" mechanism most people picture, and it's the primary driver in roughly half of cases ^[3].

Patient two has unstable breathing control (high loop gain). Here the airway isn't especially floppy. The problem is in the control system: their brain's regulation of breathing overreacts to small changes, overshooting and undershooting like a thermostat set too sensitively. This instability triggers the breathing disturbances. The anatomy might be nearly fine; the control is the issue.

Patient three has a low arousal threshold. This person wakes up too easily. A minor narrowing that another person would sleep right through instead jolts them awake, fragmenting their sleep before their body gets a chance to stabilize its own breathing. Their apnea is tangled up with the fact that they're such light sleepers, and it often overlaps with insomnia.

Patient four has mainly REM-related apnea. Their breathing is relatively stable through most of the night, but during REM sleep, the dream stage, when the body's muscles naturally relax the most, their apnea concentrates. Most of their events cluster in those REM periods.

Same score of 12. Four genuinely different diseases. And critically, the daytime experience differs too: the light sleeper with the low arousal threshold might feel exhausted and wired and struggle with insomnia, while someone with purely anatomical collapse might snore heavily and feel classically sleepy. Same number, different lives.

Phenotypes and endotypes: the how and the why

Sleep medicine has two words for these deeper layers, and they're worth knowing because they capture the whole idea.

A phenotype describes how the disease presents, the observable pattern: the symptoms, the timing, whether someone is sleepy or wired, whether their events cluster in REM, what other conditions travel with it. An endotype goes a level deeper to describe why it occurs, the underlying biological mechanism, like the collapsible airway or the unstable breathing control ^{[1, 2]}. Phenotype is the "how it shows up"; endotype is the "what's causing it."

Researchers have converged on four main endotypic traits that combine, in different proportions in different people, to produce obstructive sleep apnea: a collapsible airway, unstable ventilatory control (loop gain), a low arousal threshold, and poor responsiveness of the muscles that keep the airway open ^{[1, 2, 4]}. Most patients have a blend, but the dominant trait varies, and that's what makes two identical AHIs mean different things.

Why this matters for treatment, and for you

This isn't an academic distinction. It has direct, practical consequences for what treatment is likely to work, and it's the reason a treatment that fails one person isn't the last word for another.

CPAP, the airway-pressure machine, works across essentially all of these mechanisms, because splinting the airway open with air pressure addresses the events no matter what's driving them ^{[1, 3]}. That's a big part of why it remains the first-line, gold-standard therapy. But CPAP isn't tolerated by everyone, and that's where understanding the underlying mechanism becomes powerful.

Consider the alternatives. An oral appliance, the dental-device option, mainly works by repositioning the jaw to improve airway anatomy. So it tends to help the person whose problem is anatomical collapse, and tends to disappoint the person whose real driver is unstable breathing control or a low arousal threshold, because it doesn't touch those mechanisms ^{[5, 6]}. In fact, research shows that patients with those non-anatomical traits are more likely to be non-responders to oral appliances ^[6]. This helps explain something patients often find baffling: why a treatment that worked wonders for a friend did nothing for them. They may have had different underlying diseases all along.

The same logic is reshaping the future of sleep apnea medication. The reason there was never a simple pill for sleep apnea is that a single drug can't fix four different mechanisms. But as researchers learn to identify which trait dominates in a given patient, targeted treatments become possible: weight-loss medications that improve the anatomical component, drugs being studied to stabilize breathing control or stiffen the airway muscles, and so on ^{[4, 7]}. The whole field is moving from "here's your number, here's the standard treatment" toward "here's what's driving your apnea, here's the treatment aimed at that."

For you as a patient, the takeaways are genuinely hopeful. First, your AHI is a starting point, not the whole story, so if your symptoms don't match your number, or if a standard treatment hasn't worked, that mismatch is real information, not a dead end. Second, a failed treatment often means the approach didn't match your mechanism, not that your sleep apnea is untreatable. And third, the trend in sleep medicine is toward exactly the kind of individualized care that asks not just how severe your apnea is, but what's causing it, and matches the treatment to the answer.

Where this fits in modern, personalized sleep care

The bigger picture is that sleep medicine is following the same path as the rest of medicine: away from one-size-fits-all, toward precision. In cancer care, we no longer treat "a tumor"; we treat the specific molecular subtype. Sleep apnea is undergoing a similar shift, from treating "an AHI" to treating the specific physiology behind each person's disease.

The goal, as Dr. Taruj puts it, isn't to replace the AHI. The number still matters; it's a useful measure of how much is happening and how much risk it carries. The goal is to look beyond the single number to the biology underneath, so that care can be matched to the individual rather than the metric. That means considering symptoms, sleep patterns, other conditions, and the likely underlying mechanism together, and treating sleep apnea not as a number to be lowered but as an individual physiology to be understood. That fuller, more personalized picture is where sleep medicine is heading, and it's a far better deal for patients than a one-number verdict ever was.

The bottom line

Your AHI tells you how many times your breathing was disrupted per hour, and that's worth knowing. But it's a measurement, not a mechanism, and two people with the identical AHI can have genuinely different diseases underneath, one an airway that collapses, another a breathing-control system that's too twitchy, another a sleeper who wakes too easily, another whose apnea lives mostly in REM. Those differences shape symptoms and, crucially, which treatments will work. That's why the future of sleep medicine isn't about chasing a lower number; it's about understanding the physiology behind each patient's disease and treating accordingly. If your sleep apnea number has never quite squared with how you feel, or how you've responded to treatment, this is likely why, and it's a reason for hope, not frustration.

Frequently asked questions

This article is for general education and isn't a substitute for individual medical advice. If you have questions about your sleep apnea diagnosis or treatment, talk with a qualified clinician about what's driving your condition and which options fit you.